Summary:
An open-label, multicenter study to assess the long-term safety of once-daily study medication in subjects with moderate to severe chronic nonmalignant and nonneuropathic pain.
Qualified Participants Must:
• Be at least 18 years of age
•
Have had their predominant pain condition for at lest 3 months prior to screening
•
If pain is in low back, be above the knees
•
Be currently on a stable dose of pain medicaiton equal to 60mg of hydrocodone or greater
Qualified Participants May Receive:
All study related exams, blood work, and medications are provided free of charge and compensation is available for time and travel.